MDIC Announces Pathology ‘Collaborative Community’ With FDA Involvement
Executive Summary
This is MDIC’s third collaborative community, following groups for the US FDA’s Case for Quality and health technology.
You may also be interested in...
US FDA Touts Big Improvements In Product Review Process: Report
The US agency says it has either met or exceeded all its 2018-2020 strategic priorities, including simplifying core processes in its product review pathways.
FDA Debuts ‘Collaborative Communities’ With NESTcc, Optic Imaging Groups
The US agency is participating in collaborative communities centered around eye health and the development of real-world evidence, representing the first two of what the agency hopes will be at least 10 communities by the end of 2020.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.